Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1985 Sep;61:97–110. doi: 10.1289/ehp.856197

Structure-activity relationships of estrogens.

V C Jordan, S Mittal, B Gosden, R Koch, M E Lieberman
PMCID: PMC1568776  PMID: 3905383

Abstract

The last 50 years has seen an exponential rise in the published reports about estrogen action. The model to describe the early events in the mechanism of action of estrogens via the estrogen receptor is updated in this paper to incorporate some of the recent data on the subcellular localization of the receptor. New evidence suggests that the receptor is a nuclear protein, so it appears that estrogens must first diffuse into the nuclear compartment to initiate estrogen action via the receptor complex. This review traces the development of potent estrogenic compounds by the study of their structure-activity relationships. Studies of structure-activity relationships in vivo using Allen Doisy or 3-day uterine weight tests can provide much valuable information, but the assays suffer from the complex problems of pharmacokinetics and metabolic transformation. Studies in vitro using primary cultures of rat pituitary or uterine cells to assay the ability of a compound to induce prolactin synthesis or progesterone receptor synthesis, respectively, can provide essential information about the structural requirements for a compound to produce estrogenic effects. Nevertheless, it should be pointed out that studies in vivo are required to determine whether a compound is metabolically activated to an estrogen. Estrogen receptor binding models are presented to describe the changes in a molecule that will predict high affinity for the ligand and agonist, partial agonist and antagonist properties of the ligand-receptor complex. Most estrogenic pesticides and phytoestrogens comform to the predictions of the estrogen receptor binding model.

Full text

PDF
97

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen K. E., Clark E. R., Jordan V. C. Evidence for the metabolic activation of non-steroidal antioestrogens: a study of structure-activity relationships. Br J Pharmacol. 1980;71(1):83–91. doi: 10.1111/j.1476-5381.1980.tb10912.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Axelson M., Sjövall J., Gustafsson B. E., Setchell K. D. Origin of lignans in mammals and identification of a precursor from plants. Nature. 1982 Aug 12;298(5875):659–660. doi: 10.1038/298659a0. [DOI] [PubMed] [Google Scholar]
  3. BELLEAU B. A MOLECULAR THEORY OF DRUG ACTION BASED ON INDUCED CONFORMATIONAL PERTURBATIONS OF RECEPTORS. J Med Chem. 1964 Nov;7:776–784. doi: 10.1021/jm00336a022. [DOI] [PubMed] [Google Scholar]
  4. BICKOFF E. M., BOOTH A. N., LYMAN R. L., LIVINGSTON A. L., THOMPSON C. R., DEEDS F. Coumestrol, a new estrogen isolated from forage crops. Science. 1957 Nov 8;126(3280):969–970. doi: 10.1126/science.126.3280.969-a. [DOI] [PubMed] [Google Scholar]
  5. BICKOFF E. M., LIVINGSTON A. L., BOOTH A. N. TRICIN FROM ALFALFA--ISOLATION AND PHYSIOLOGICAL ACTIVITY. J Pharm Sci. 1964 Nov;53:1411–1412. doi: 10.1002/jps.2600531131. [DOI] [PubMed] [Google Scholar]
  6. BRADBURY R. B., WHITE D. E. Estrogens and related substances in plants. Vitam Horm. 1954;12:207–233. doi: 10.1016/s0083-6729(08)61013-4. [DOI] [PubMed] [Google Scholar]
  7. Boyd P. A., Wittliff J. L. Mechanism of Fusarium mycotoxin action in mammary gland. J Toxicol Environ Health. 1978 Jan;4(1):1–8. doi: 10.1080/15287397809529638. [DOI] [PubMed] [Google Scholar]
  8. Bulger W. H., Kupfer D. Estrogenic action of DDT analogs. Am J Ind Med. 1983;4(1-2):163–173. [PubMed] [Google Scholar]
  9. Bulger W. H., Muccitelli R. M., Kupfer D. Interactions of methoxychlor, methoxychlor base-soluble contaminant, and 2,2-bis(p-hydroxyphenyl)-1,1,1-trichloroethane with rat uterine estrogen receptor. J Toxicol Environ Health. 1978 Sep-Nov;4(5-6):881–893. doi: 10.1080/15287397809529709. [DOI] [PubMed] [Google Scholar]
  10. Bulger W. H., Muccitelli R. M., Kupfer D. Studies on the in vivo and in vitro estrogenic activities of methoxychlor and its metabolites. Role of hepatic mono-oxygenase in methoxychlor activation. Biochem Pharmacol. 1978;27(20):2417–2423. doi: 10.1016/0006-2952(78)90354-4. [DOI] [PubMed] [Google Scholar]
  11. Bülbring E., Burn J. H. The estimation of oestrin and of male hormone in oily solution. J Physiol. 1935 Nov 22;85(3):320–333. doi: 10.1113/jphysiol.1935.sp003321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. CHENG E., YODER L., STORY C. D., BURROUGHS W. Estrogenic activity of some isoflavone derivatives. Science. 1954 Oct 8;120(3119):575–576. doi: 10.1126/science.120.3119.575. [DOI] [PubMed] [Google Scholar]
  13. Clark J. H., Guthrie S. C. Agonistic and antagonistic effects of clomiphene citrate and its isomers. Biol Reprod. 1981 Oct;25(3):667–672. doi: 10.1095/biolreprod25.3.667. [DOI] [PubMed] [Google Scholar]
  14. Clark J. H., Paszko Z., Peck E. J., Jr Nuclear binding and retention of the receptor estrogen complex: relation to the agonistic and antagonistic properties of estriol. Endocrinology. 1977 Jan;100(1):91–96. doi: 10.1210/endo-100-1-91. [DOI] [PubMed] [Google Scholar]
  15. DODDS E. C., FOLLEY S. J., GLASCOCK R. F., LAWSON W. The excretion of microgram doses of hexoestrol by rabbits and rats. Biochem J. 1958 Jan;68(1):161–167. doi: 10.1042/bj0680161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Dix C. J., Jordan V. C. Modulation of rat uterine steroid hormone receptors by estrogen and antiestrogen. Endocrinology. 1980 Dec;107(6):2011–2020. doi: 10.1210/endo-107-6-2011. [DOI] [PubMed] [Google Scholar]
  17. Dix C. J., Jordan V. C. Subcellular effects of monohydroxytamoxifen in the rat uterus: steroid receptors and mitosis. J Endocrinol. 1980 Jun;85(3):393–404. doi: 10.1677/joe.0.0850393. [DOI] [PubMed] [Google Scholar]
  18. Dorfman R. I., Kincl F. A. Uterotrophic activity of various phenolic steroids. Acta Endocrinol (Copenh) 1966 Aug;52(4):619–626. doi: 10.1530/acta.0.0520619. [DOI] [PubMed] [Google Scholar]
  19. Durani S., Agarwal A. K., Saxena R., Setty B. S., Gupta R. C., Kole P. L., Ray S., Anand N. Seco-oestradiols and some non-steroidal oestrogens: structural correlates of oestrogenic action. J Steroid Biochem. 1979 Jul;11(1A):67–77. doi: 10.1016/0022-4731(79)90278-4. [DOI] [PubMed] [Google Scholar]
  20. EMMENS C. W. The intravaginal assay of naturally occurring oestrogens. J Endocrinol. 1950 Jan;6(3):302–307. doi: 10.1677/joe.0.0060302. [DOI] [PubMed] [Google Scholar]
  21. Eisenfeld A. Oral contraceptives: ethinyl estradiol binds with higher affinity than mestranol to macromolecules from the sites of anti-fertility action. Endocrinology. 1974 Mar;94(3):803–807. doi: 10.1210/endo-94-3-803. [DOI] [PubMed] [Google Scholar]
  22. Farnsworth N. R., Bingel A. S., Cordell G. A., Crane F. A., Fong H. S. Potential value of plants as sources of new antifertility agents II. J Pharm Sci. 1975 May;64(5):717–754. doi: 10.1002/jps.2600640504. [DOI] [PubMed] [Google Scholar]
  23. GLASCOCK R. F., HOEKSTRA W. G. Selective accumulation of tritium-labelled hexoestrol by the reproductive organs of immature female goats and sheep. Biochem J. 1959 Aug;72:673–682. doi: 10.1042/bj0720673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. GREENBLATT R. B., BROWN N. H. The storage of estrogen in human fat after estrogen administration. Am J Obstet Gynecol. 1952 Jun;63(6):1361–1363. doi: 10.1016/s0002-9378(16)38939-6. [DOI] [PubMed] [Google Scholar]
  25. Garg S., Bindal R. D., Durani S., Kapil R. S. Structure-activity relationship of estrogens: a study involving cyclofenyl as the model compound. J Steroid Biochem. 1983 Jan;18(1):89–95. doi: 10.1016/0022-4731(83)90335-7. [DOI] [PubMed] [Google Scholar]
  26. Gorski J., Toft D., Shyamala G., Smith D., Notides A. Hormone receptors: studies on the interaction of estrogen with the uterus. Recent Prog Horm Res. 1968;24:45–80. doi: 10.1016/b978-1-4831-9827-9.50008-3. [DOI] [PubMed] [Google Scholar]
  27. Hahn D. W., McGuire J. L., Greenslade F. C., Turner G. D., DaVanzo J. P. Molecular parameters involved in the estrogenicity of mestranol and ethynylestradiol. Proc Soc Exp Biol Med. 1971 Sep;137(4):1180–1185. doi: 10.3181/00379727-137-35751. [DOI] [PubMed] [Google Scholar]
  28. Hammond B., Katzenellenbogen B. S., Krauthammer N., McConnell J. Estrogenic activity of the insecticide chlordecone (Kepone) and interaction with uterine estrogen receptors. Proc Natl Acad Sci U S A. 1979 Dec;76(12):6641–6645. doi: 10.1073/pnas.76.12.6641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Harper M. J., Walpole A. L. Contrasting endocrine activities of cis and trans isomers in a series of substituted triphenylethylenes. Nature. 1966 Oct 1;212(5057):87–87. doi: 10.1038/212087a0. [DOI] [PubMed] [Google Scholar]
  30. Hähnel R., Twaddle E., Ratajczak T. The specificity of the estrogen receptor of human uterus. J Steroid Biochem. 1973 Jan;4(1):21–31. doi: 10.1016/0022-4731(73)90076-9. [DOI] [PubMed] [Google Scholar]
  31. Ireland J. S., Mukku V. R., Robison A. K., Stancel G. M. Stimulation of uterine deoxyribonucleic acid synthesis by 1,1,1-trichloro-2-(p-chlorophenyl)-2-(o-chlorophenyl)ethane (o,p'-DDT). Biochem Pharmacol. 1980 Jun 1;29(11):1469–1474. doi: 10.1016/0006-2952(80)90596-1. [DOI] [PubMed] [Google Scholar]
  32. Jensen E. V., DeSombre E. R. Estrogen-receptor interaction. Science. 1973 Oct 12;182(4108):126–134. doi: 10.1126/science.182.4108.126. [DOI] [PubMed] [Google Scholar]
  33. Jordan V. C., Collins M. M., Rowsby L., Prestwich G. A monohydroxylated metabolite of tamoxifen with potent antioestrogenic activity. J Endocrinol. 1977 Nov;75(2):305–316. doi: 10.1677/joe.0.0750305. [DOI] [PubMed] [Google Scholar]
  34. Jordan V. C., Haldemann B., Allen K. E. Geometric isomers of substituted triphenylethylenes and antiestrogen action. Endocrinology. 1981 Apr;108(4):1353–1361. doi: 10.1210/endo-108-4-1353. [DOI] [PubMed] [Google Scholar]
  35. Jordan V. C., Naylor K. E. The binding of [3H]-oestradiol-17 beta in the immature rat uterus during the sequential administration of non-steroidal anti-oestrogens. Br J Pharmacol. 1979 Feb;65(2):167–173. doi: 10.1111/j.1476-5381.1979.tb07815.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Jordan V. C. Prolonged antioestrogenic activity of ICI 46, 474 in the ovariectomized mouse. J Reprod Fertil. 1975 Feb;42(2):251–258. doi: 10.1530/jrf.0.0420251. [DOI] [PubMed] [Google Scholar]
  37. Jordan V. C., Rowsby L., Dix C. J., Prestwich G. Dose-related effects of non-steroidal antioestrogens nad oestrogens on the measurement of cytoplasmic oestrogen receptors in the rat and mouse uterus. J Endocrinol. 1978 Jul;78(1):71–81. doi: 10.1677/joe.0.0780071. [DOI] [PubMed] [Google Scholar]
  38. Kassis J. A., Sakai D., Walent J. H., Gorski J. Primary cultures of estrogen-responsive cells from rat uteri: induction of progesterone receptors and a secreted protein. Endocrinology. 1984 May;114(5):1558–1566. doi: 10.1210/endo-114-5-1558. [DOI] [PubMed] [Google Scholar]
  39. Kiang D. T., Kennedy B. J., Pathre S. V., Mirocha C. J. Binding characteristics of zearalenone analogs to estrogen receptors. Cancer Res. 1978 Nov;38(11 Pt 1):3611–3615. [PubMed] [Google Scholar]
  40. King W. J., Greene G. L. Monoclonal antibodies localize oestrogen receptor in the nuclei of target cells. Nature. 1984 Feb 23;307(5953):745–747. doi: 10.1038/307745a0. [DOI] [PubMed] [Google Scholar]
  41. Korenman S. G. Comparative binding affinity of estrogens and its relation to estrogenic potency. Steroids. 1969 Feb;13(2):163–177. doi: 10.1016/0039-128x(69)90004-x. [DOI] [PubMed] [Google Scholar]
  42. Kupfer D., Bulger W. H. A novel in vitro method for demonstrating proestrogens. Metabolism of methoxychlor and o,p'DDT by liver microsomes in the presence of uteri and effects on intracellular distribution of estrogen receptors. Life Sci. 1979 Sep 11;25(11):975–983. doi: 10.1016/0024-3205(79)90503-4. [DOI] [PubMed] [Google Scholar]
  43. Kupfer D. Effects of pesticides and related compounds on steroid metabolism and function. CRC Crit Rev Toxicol. 1975 Oct;4(1):83–124. doi: 10.1080/10408447509163835. [DOI] [PubMed] [Google Scholar]
  44. LERNER L. J., TURKHEIMER A. R., BORMAN A. PHLORETIN, A WEAK ESTROGEN AND ESTROGEN ANTAGONIST. Proc Soc Exp Biol Med. 1963 Oct;114:115–117. doi: 10.3181/00379727-114-28601. [DOI] [PubMed] [Google Scholar]
  45. Lieberman M. E., Gorski J., Jordan V. C. An estrogen receptor model to describe the regulation of prolactin synthesis by antiestrogens in vitro. J Biol Chem. 1983 Apr 25;258(8):4741–4745. [PubMed] [Google Scholar]
  46. Lieberman M. E., Jordan V. C., Fritsch M., Santos M. A., Gorski J. Direct and reversible inhibition of estradiol-stimulated prolactin synthesis by antiestrogens in vitro. J Biol Chem. 1983 Apr 25;258(8):4734–4740. [PubMed] [Google Scholar]
  47. Lieberman M. E., Maurer R. A., Gorski J. Estrogen control of prolactin synthesis in vitro. Proc Natl Acad Sci U S A. 1978 Dec;75(12):5946–5949. doi: 10.1073/pnas.75.12.5946. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Lippman M. E., Bolan G. Oestrogen-responsive human breast cancer in long term tissue culture. Nature. 1975 Aug 14;256(5518):592–593. doi: 10.1038/256592a0. [DOI] [PubMed] [Google Scholar]
  49. MARTIN L., CLARINGBOLD P. J. A highly sensitive assay for oestrogens. Nature. 1958 Mar 1;181(4609):620–621. doi: 10.1038/181620b0. [DOI] [PubMed] [Google Scholar]
  50. MARTIN L. The use of 2-3-5-triphenyltetrazolium chloride in the biological assay of oestrogens. J Endocrinol. 1960 May;20:187–197. doi: 10.1677/joe.0.0200187. [DOI] [PubMed] [Google Scholar]
  51. MICHELI R. A., BOOTH A. N., LIVINGSTON A. L., BICKOFF E. M. COUMESTROL, PLANT PHENOLICS, AND SYNTHETIC ESTROGENS: A CORRELATION OF STRUCTURE AND ACTIVITY. J Med Pharm Chem. 1962 Mar;5:321–335. doi: 10.1021/jm01237a010. [DOI] [PubMed] [Google Scholar]
  52. Martin P. M., Horwitz K. B., Ryan D. S., McGuire W. L. Phytoestrogen interaction with estrogen receptors in human breast cancer cells. Endocrinology. 1978 Nov;103(5):1860–1867. doi: 10.1210/endo-103-5-1860. [DOI] [PubMed] [Google Scholar]
  53. Nelson J. A. Effects of dichlorodiphenyltrichloroethane (DDT) analogs and polychlorinated biphenyl (PCB) mixtures on 17beta-(3H)estradiol binding to rat uterine receptor. Biochem Pharmacol. 1974 Jan 15;23(2):447–451. doi: 10.1016/0006-2952(74)90436-5. [DOI] [PubMed] [Google Scholar]
  54. Nelson J. A., Struck R. F., James R. Estrogenic activities of chlorinated hydrocarbons. J Toxicol Environ Health. 1978 Mar-May;4(2-3):325–339. doi: 10.1080/15287397809529664. [DOI] [PubMed] [Google Scholar]
  55. Ousterhout J., Struck R. F., Nelson J. A. Estrogenic activities on methoxychlor metabolites. Biochem Pharmacol. 1981 Oct;30(20):2869–2871. doi: 10.1016/0006-2952(81)90429-9. [DOI] [PubMed] [Google Scholar]
  56. Pento J. T., Magarian R. A., Wright R. J., King M. M., Benjamin E. J. Nonsteroidal estrogens and antiestrogens: biological activity of cyclopropyl analogs of stilbene and stilbenediol. J Pharm Sci. 1981 Apr;70(4):399–403. doi: 10.1002/jps.2600700415. [DOI] [PubMed] [Google Scholar]
  57. RUBIN B. L., DORFMAN A. S., BLACK L., DORFMAN R. I. Bioassay of estrogens using the mouse uterine response. Endocrinology. 1951 Oct;49(4):429–439. doi: 10.1210/endo-49-4-429. [DOI] [PubMed] [Google Scholar]
  58. Setchell K. D., Lawson A. M., Mitchell F. L., Adlercreutz H., Kirk D. N., Axelson M. Lignans in man and in animal species. Nature. 1980 Oct 23;287(5784):740–742. doi: 10.1038/287740a0. [DOI] [PubMed] [Google Scholar]
  59. Shutt D. A., Cox R. I. Steroid and phyto-oestrogen binding to sheep uterine receptors in vitro. J Endocrinol. 1972 Feb;52(2):299–310. doi: 10.1677/joe.0.0520299. [DOI] [PubMed] [Google Scholar]
  60. Shutt D. A. The effects of plant oestrogens on animal reproduction. Endeavour. 1976 Sep;35(126):110–113. doi: 10.1016/0160-9327(76)90004-1. [DOI] [PubMed] [Google Scholar]
  61. Stitch S. R., Toumba J. K., Groen M. B., Funke C. W., Leemhuis J., Vink J., Woods G. F. Excretion, isolation and structure of a new phenolic constituent of female urine. Nature. 1980 Oct 23;287(5784):738–740. doi: 10.1038/287738a0. [DOI] [PubMed] [Google Scholar]
  62. THOMPSON C. R., WERNER H. W. Fat storage of an estrogen in women following orally administered tri-p-anisylchloroethylene. Proc Soc Exp Biol Med. 1953 Nov;84(2):491–492. doi: 10.3181/00379727-84-20688. [DOI] [PubMed] [Google Scholar]
  63. THOMPSON C. R., WERNER H. W. Studies on estrogen tri-p-anisylchloroethylene. Proc Soc Exp Biol Med. 1951 Jul;77(3):494–497. doi: 10.3181/00379727-77-18826. [DOI] [PubMed] [Google Scholar]
  64. Tate A. C., DeSombre E. R., Greene G. L., Jensen E. V., Jordan V. C. Interaction of [3H] estradiol - and [3H] monohydroxytamoxifen-estrogen receptor complexes with a monoclonal antibody. Breast Cancer Res Treat. 1983;3(3):267–277. doi: 10.1007/BF01806700. [DOI] [PubMed] [Google Scholar]
  65. Terenius L. Effect of synthetic oestrogens and analogues on the uptake of oestradiol by the immature mouse uterus and vagina. Acta Pharmacol Toxicol (Copenh) 1966;24(1):89–100. doi: 10.1111/j.1600-0773.1966.tb00371.x. [DOI] [PubMed] [Google Scholar]
  66. Terenius L. Uptake of radioactive oestradiol in some organs of immature mice. The capacity and structural specificity of uptake studied with several steroid hormones. Acta Endocrinol (Copenh) 1965 Dec;50(4):584–596. [PubMed] [Google Scholar]
  67. WENZEL D. G., ROSENBERG P. Estrogenic activity of some flavonoids. J Am Pharm Assoc Am Pharm Assoc. 1956 Jun;45(6):367–369. doi: 10.1002/jps.3030450604. [DOI] [PubMed] [Google Scholar]
  68. Welshons W. V., Lieberman M. E., Gorski J. Nuclear localization of unoccupied oestrogen receptors. Nature. 1984 Feb 23;307(5953):747–749. doi: 10.1038/307747a0. [DOI] [PubMed] [Google Scholar]
  69. Zondek B., Bergmann E. Phenol methyl ethers as oestrogenic agents. Biochem J. 1938 Apr;32(4):641–645. doi: 10.1042/bj0320641. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES